In concert with the growing demand for greater volumes of biotech nanoparticles, Particle Works has been launched as a new source for the automation of nanoparticle engineering and production. The company says that magnetic nanoparticles […]
With its acquisition of nanoComposix, fast-growing Fortis Life Sciences is emerging as a new force in the field of magnetic particle development and manufacturing. The venture capital-backed firm acquired nanomaterials company nanoComposix and three others […]
Imagion Biosystems is progressing to clinical studies of the efficacy of its MagSense magnetic particles for early detection of cancer, marking an important advancement for the Melbourne biotech firm that is pioneering the application of magnetic particles beyond […]
Fresh from success battling Covid-19, Australian biotech company AnteoTech is setting up for rapid expansion based upon its AnteoBind technology for improved molecular conjugation. Armed with $12 million in new funding, the company is developing more tests and its […]
Imagion Biosystems Ltd. has announced that NewPhase Ltd., an Israeli biotechnology company developing cancer treatments, has placed an order totaling approximately $300,000 for the supply of Imagion’s magnetic nanoparticles. Headquartered in Melbourne, Australia, Imagion is a developer of magnetic nanoparticles and a […]
Scientists at Lawrence Berkeley National Laboratory have made a new material that is both liquid and magnetic, opening the door to a new area of science and potential product development in magnetic soft matter. Basically, they have managed to print magnetic liquid droplets. Their […]
Copyright © 2024 | MH Magazine WordPress Theme by MH Themes